Other News

IRRAS Announces Key IRRAflow Commercial Milestones in Germany

STOCKHOLM, Oct. 22, 2020 /PRNewswire/ — IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced important commercial milestones from the launch of its IRRAflow system in Germany. The company generated its initial revenue in Germany and also completed the first German patient since launching the most recent […]

FibroGen Presents Late-Breaker Abstract Results on Associations between Hemoglobin Levels and Cardiovascular Outcomes in Roxadustat-Treated Patients with Anemia of Chronic Kidney Disease (CKD)

In non-dialysis and dialysis-dependent CKD patients, Major Adverse Cardiovascular Event (MACE) and MACE+ incidence rates were lowest when patients achieved hemoglobin levels ≥ 10 g/dL Two analyses of pooled data from the roxadustat global Phase 3 development program to be presented during the American Society of Nephrology Kidney Week 2020 Reimagined SAN FRANCISCO, Oct. 22, 2020 […]

St. Luke’s University Health Network Selects GE Healthcare for $11 Million Ultrasound Purchase to Create System-wide Efficiencies

GE Healthcare will install 76 ultrasound systems in 2020 to deploy a fleet of AI-powered technology, making this GE Healthcare’s largest ever single-order ultrasound deal in the U.S. Equipment will enhance standardizing care in radiology, vascular and echocardiography GE Healthcare’s Viewpoint 6 automated reporting and post-processing system expected to save […]

Dicerna Presents Positive New Interim Data From PHYOX™3 Long-Term, Open-Label Extension Study of Nedosiran for Treatment of Primary Hyperoxaluria (PH)

– All Participants Receiving Nedosiran, Regardless of Subtype, Achieved Normalization or Near-Normalization of Urinary Oxalate, a Key PH Measure, by Day 180 in Ongoing, Open-Label Trial – – Nedosiran Was Generally Well Tolerated With No Serious Safety Concerns Identified in This Ongoing Study – LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) […]

SimonMed Imaging partners with Philips to deploy new diagnostic imaging technology to advance radiology workflow performance

October 21, 2020 SimonMed will introduce Philips’ state-of-the-art 3T MR services to help improve patient care while increasing patient and staff satisfaction at a lower cost Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that SimonMed Imaging, one of the largest outpatient imaging […]

Hatch Medical and VascuTech Medical Partner to Commercialize Advanced Radial Sheath and Micro-Introducer Lines

SANTA ROSA BEACH, Fla., Oct. 20, 2020 (GLOBE NEWSWIRE) — Medical device incubator and technology brokerage firm, Hatch Medical, L.L.C. (www.hatchmedical.com) announced recently that it has entered into an exclusive brokerage relationship with VascuTech Medical and Interventional Radiologist Jonathan Levine, MD for their next generation sheath technology. “Dr. Levine, a […]

InCarda Therapeutics Raises $30 Million Through First Close of Series C Equity Financing

Proceeds to Support Ongoing Clinical Development of InRhythm™, A First-of-its-Kind Inhaled Antiarrhythmic for Treatment of Paroxysmal Atrial Fibrillation (PAF) Positive Phase 2 Data Scheduled for Presentation at American Heart Association Scientific Sessions 2020; Pivotal Phase 3 Study Planned for Initiation in H1 2021 SAN FRANCISCO, Oct. 21, 2020 (GLOBE NEWSWIRE) —  InCarda Therapeutics, […]

FLEX Vessel Prep™ System Receives New Indication to Address In-Stent Restenosis

MINNEAPOLIS, Oct. 21, 2020 /PRNewswire/ — VentureMed Group, Inc. (VentureMed), a privately-held medical device innovator in vessel preparation for interventional treatment of peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced today that the U.S. Food and Drug Administration (FDA) cleared the Company’s FLEX Vessel Prep™ System for use in […]

Aidoc granted AI industry-first FDA clearance for triage of incidental pulmonary embolism

This is the company’s 6th FDA clearance and further solidifies its leadership as the most comprehensive acute AI vendor in the market NEW YORK, Oct. 21, 2020 /PRNewswire/ — Aidoc announced today that the US Food and Drug Administration (FDA) has given regulatory clearance for the commercial use of its triaging and notification algorithms […]